ESPR,Esperion Therapeutics, Inc. | Healthcare

Healthcare

ESPR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Esperion Therapeutics, Inc.ESPR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

193.32M

Revenue (ttm)

332.31M

Net Income (ttm)

-51.75M

Shares Out

197.85M

EPS (ttm)

-0.28

PE Ratio

n/a

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

n/a

Open

0.9800

Previous Close

0.9600

Day's Range

0.9500 - 1.0200

52-Week Range

0.9300 - 3.9400

Beta

0.86

Analysts

Buy

Price Target

6.21 (+535.55%)

Earnings Date

May 6, 2025

Description >

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol.

Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.

The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program.

Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Latest News >

Markets at close: How the major indices and stocks fared on Thursday

Jul 18, 2019

The 30-share benchmark Sensex settled 318 points lower, or 0.81 percent, at 38,897.

Closing Bell: Sensex ends 318 points lower, Nifty gives up 11600, midcaps fall sharply, Yes Bank plunges 12.5%

Jul 17, 2019

Indian shares ended Thursday's trade with sharp losses dragged by bank, auto and metal stocks in particular, amid weak global cues as concerns over the US-China trade war weighed on investors' risk appetite. Trading was also cautious amid the ongoing first-quarter earnings season and continued selling by foreign investors in domestic equity. The Sensex trades ended below 39,000, while the Nifty gave up 11,600. Yes Bank shares fell sharply after disappointing first quarter results. Wipro shares have surged. Here are the main highlights from the stock markets today:

These NSE stocks hit their 52-week highs and lows on July 18

Jul 18, 2019

Indian benchmark indices extended losses around noon on Thursday as corporate earnings remained poor and broader Asian shares remained under pressure due to resurfacing of US-China trade war. At 02.43 pm, the BSE Sensex was down 142.11 points, or 0.36 percent, at 39,073.53, and the Nifty 50 was trading 45.20 points, or 0.39 percent, lower at 11,642.30. Here are some stocks that hit their 52-week highs or lows on the NSE on July 18.

Closing Bell: Sensex ends 318 points lower, Nifty below 11,600; Yes Bank cracks 12.6%

Jul 18, 2019

The Sensex ended 318 points lower at 38,897, while the broader Nifty50 index lost 91 points to end at 11,597.